Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMD

Clinical trial NCT02810808 · UNKNOWN

Trial details

NCT number

NCT02810808

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Status

UNKNOWN

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2013-12-01

Primary completion

2016-09-01

Enrollment

115

View on ClinicalTrials.gov